Aggregation of human platelets by amniotic fluid.
Twenty-four amniotic fluid samples were examined for their effects on human platelets. All samples caused irreversible platelet aggregation. The active material precipitated with high-speed ultracentrifugation and was completely inhibited by prior incubation with purified collagenase. The presence of free collagen in amniotic fluid was further confirmed by polyacrylamide-gel electrophoresis and hydroxyproline assays. Beside platelet-aggregating activity, amniotic fluid samples were also shown to significantly shorten the recalcification time of normal plasma. This procoagulant activity appears to be related to the presence of thromboplastin, collagen and other as yet unidentified procoagulant material in amniotic fluid. The presence of activators of platelets and clotting factors in amniotic fluid would account for the strong clot-promoting activity of this fluid. These studies suggest that the ideal management of the coagulopathy of pregnancy should include a combination of anticoagulant and antiplatelet drugs.
D000653:Amniotic Fluid / Q000032:analysis / Q000502:physiology*; D001241:Aspirin / Q000494:pharmacology; D001779:Blood Coagulation Factors; D003094:Collagen / Q000032:analysis / Q000502:physiology; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects
D001779:Blood Coagulation Factors; D003094:Collagen; D001241:Aspirin